As with any training program, the goal of supplementation is to ensure maximum performance is achieved alongside simultaneous optimal recovery as well
32 Furthermore, subsequent large retrospective studies have demonstrated no effect of GLP-1RA on the increased risk of ischemic optic neuropathy
Michl, Martin (Department of Ophthalmology, Medical University of Vienna), Mitsch, Christoph (Department of Ophthalmology, Medical University of Vienna)
Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials
No amount of mixing is completely without risk or consequences
